{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:50:08Z","timestamp":1789095008172,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020328","name":"University of Petra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.arr.2023.102143","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T07:25:18Z","timestamp":1700897118000},"page":"102143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Calprotectin in Parkinsonian disease: Anticipation and dedication"],"prefix":"10.1016","volume":"93","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayah Talal","family":"Zaidalkiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Bahaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"AL-Faraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2023.102143_bib1","article-title":"Role of using nonsteroidal anti-inflammatory drugs in chemoprevention of colon cancer in patients with inflammatory bowel disease","volume":"12","author":"Abdalla","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.arr.2023.102143_bib2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jnr.25171","article-title":"SARS\u2010COV\u20102 infection and Parkinson's disease: Possible links and perspectives","volume":"101","author":"Al\u2010kuraishy","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2023.102143_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102075","article-title":"The conceivable role of prolactin hormone in Parkinson disease: the same goal but with different ways","author":"Al-Kuraishy","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2023.102143_bib4","first-page":"1","article-title":"Metformin role in Parkinson\u2019s disease: a double-sword effect","author":"Alrouji","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.arr.2023.102143_bib5","first-page":"1","article-title":"Orexin pathway in Parkinson\u2019s disease: a review","author":"Alrouji","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.arr.2023.102143_bib6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10787-023-01192-2","article-title":"A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson\u2019s disease: beneficial or detrimental effects","volume":"31","author":"Alrouji","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.arr.2023.102143_bib7","first-page":"1","article-title":"DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson\u2019s disease: a mutual relationship","author":"Alrouji","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.arr.2023.102143_bib8","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1111\/bph.14449","article-title":"Calprotectin protects against experimental colonic inflammation in mice","volume":"175","author":"Aranda","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.102143_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104782","article-title":"Genetics of Parkinson's disease: an introspection of its journey towards precision medicine","volume":"137","author":"Bandres-Ciga","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2023.102143_bib10","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","article-title":"Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT","volume":"87","author":"Barichella","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2023.102143_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10787-022-01125-5","article-title":"SIRT1 pathway in Parkinson\u2019s disease: a faraway snapshot but so close","volume":"31","author":"Batiha","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.arr.2023.102143_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4049\/jimmunol.1601247","article-title":"Microbiome-modulated metabolites at the interface of host immunity","volume":"198","author":"Blacher","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.arr.2023.102143_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","article-title":"Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?","volume":"23","author":"Blesa","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2023.102143_bib14","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2023.102143_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00365521.2019.1585939","article-title":"Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated\u2013an open-label pilot study","volume":"54","author":"Cold","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.arr.2023.102143_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fnins.2021.689723","article-title":"Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson\u2019s disease","volume":"15","author":"Dumitrescu","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2023.102143_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/acn3.772","article-title":"Green A,Group BLS, \u03b1\u2010synuclein RT\u2010QuIC in cerebrospinal fluid of LRRK 2\u2013linked Parkinson's disease","volume":"6","author":"Garrido","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2023.102143_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/bs11050074","article-title":"Cognitive impairment in Parkinson\u2019s disease: epidemiology, clinical profile, protective and risk factors","volume":"11","author":"Gonzalez-Latapi","year":"2021","journal-title":"Behav. Sci."},{"key":"10.1016\/j.arr.2023.102143_bib19","article-title":"Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota","volume":"7","author":"Harach","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2023.102143_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1756283X12459294","article-title":"Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation","volume":"6","author":"Hemarajata PVersalovic","year":"2013","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.arr.2023.102143_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41390-018-0254-y","article-title":"Enteric dysbiosis and fecal calprotectin expression in premature infants","volume":"85","author":"Ho","year":"2019","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.arr.2023.102143_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","article-title":"Gut microbiota in Parkinson disease in a northern German cohort","volume":"1667","author":"Hopfner","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2023.102143_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.14802\/jmd.21085","article-title":"Fecal calprotectin in Parkinson\u2019s disease and multiple system atrophy","volume":"15","author":"Hor","year":"2022","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.arr.2023.102143_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5455\/medarh.2016.70.445-448","article-title":"Psychological stress and changes of hypothalamic-pituitary-adrenal axis in patients with \u201cde novo\u201d Parkinson\u2019s disease","volume":"70","author":"Ibrahimagic","year":"2016","journal-title":"Med. Arch."},{"key":"10.1016\/j.arr.2023.102143_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1001025","article-title":"From bench to bedside: Calprotectin (S100A8\/S100A9) as a biomarker in rheumatoid arthritis","volume":"13","author":"Inciarte-Mundo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2023.102143_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2021.101966","article-title":"Pesticides and Parkinson\u2019s disease: Current and future perspective","volume":"115","author":"Islam","year":"2021","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.arr.2023.102143_bib27","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: from biomarker to biological function","volume":"70","author":"Jukic","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.arr.2023.102143_bib28","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1080\/00365520701395945","article-title":"Gastrointestinal symptoms are associated with hypothalamic-pituitary-adrenal axis suppression in healthy individuals","volume":"42","author":"Karling","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.arr.2023.102143_bib29","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.3390\/cimb44100304","article-title":"Oral cavity calprotectin and Lactoferrin levels in relation to radiotherapy","volume":"44","author":"Keskin","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.arr.2023.102143_bib30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cca.2020.08.025","article-title":"Calprotectin in inflammatory bowel disease","volume":"510","author":"Khaki-Khatibi","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.arr.2023.102143_bib31","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.3390\/ijms21113968","article-title":"Reduced fecal calprotectin and inflammation in a murine model of atopic dermatitis following probiotic treatment","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.102143_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","article-title":"Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model","volume":"69","author":"Kim","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.arr.2023.102143_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-019-2018-4","article-title":"A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin","volume":"21","author":"Klingberg","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.arr.2023.102143_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5056\/jnm18087","article-title":"Brain-gut-microbiota axis in Alzheimer\u2019s disease","volume":"25","author":"Kowalski KMulak","year":"2019","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.arr.2023.102143_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00702-015-1381-9","article-title":"Elevated fecal calprotectin in patients with Alzheimer\u2019s dementia indicates leaky gut","volume":"122","author":"Leblhuber","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2023.102143_bib36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gutjnl-2020-322429","article-title":"Inflammatory bowel disease and Parkinson\u2019s disease: common pathophysiological links","volume":"70","author":"Lee","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.arr.2023.102143_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/00365521.2019.1566493","article-title":"Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy","volume":"54","author":"Lundgren","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.arr.2023.102143_bib38","first-page":"1","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation","author":"Metta","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2023.102143_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00992","article-title":"Fecal calprotectin as a marker of the gut immune system activation is elevated in Parkinson\u2019s disease","volume":"13","author":"Mulak","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2023.102143_bib40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41579-022-00745-6","article-title":"Nutritional immunity: the battle for nutrient metals at the host\u2013pathogen interface","volume":"20","author":"Murdoch CCSkaar","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.arr.2023.102143_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2019.10.1144","article-title":"Gastrointestinal disturbances in various forms of parkinsonism","volume":"405","author":"Naimov","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2023.102143_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/bs.pbr.2020.09.011","article-title":"Co-administration of TiO2-nanowired dl-3-n-butylphthalide (dl-NBP) and mesenchymal stem cells enhanced neuroprotection in Parkinson's disease exacerbated by concussive head injury","volume":"258","author":"Niu","year":"2020","journal-title":"Prog. brain Res."},{"key":"10.1016\/j.arr.2023.102143_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2023.102143_bib44","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep4.1905","article-title":"Gut dysbiosis and fecal calprotectin predict response to immune checkpoint inhibitors in patients with hepatocellular carcinoma","volume":"6","author":"Ponziani","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.arr.2023.102143_bib45","unstructured":"Prada ARdSL, Studies on the Role of Calprotectin as a Mediator of Iron-Induced Inflammation with Implications in Parkinson's Disease. 2019, Universidade de Lisboa (Portugal)."},{"key":"10.1016\/j.arr.2023.102143_bib46","article-title":"Astrocytic atrophy as a pathological feature of Parkinson\u2019s disease with LRRK2 mutation","volume":"7","author":"Ramos-Gonzalez","year":"2021","journal-title":"npj Park. 'S. Dis."},{"key":"10.1016\/j.arr.2023.102143_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10408363.2019.1619159","article-title":"Clinical value of fecal calprotectin","volume":"56","author":"Ricciuto AGriffiths","year":"2019","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.arr.2023.102143_bib48","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00415-019-09321-0","article-title":"Is Parkinson\u2019s disease a chronic low-grade inflammatory bowel disease","volume":"267","author":"Rolli-Derkinderen","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2023.102143_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-022-02220-1","article-title":"The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis","volume":"22","author":"Ross","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.arr.2023.102143_bib50","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.3390\/ijerph17207575","article-title":"Serum calprotectin and chemerin concentrations as markers of low-grade inflammation in prepubertal children with obesity","volume":"17","author":"Rowicka","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.arr.2023.102143_bib51","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.arr.2023.102143_bib52","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/medicina58101384","article-title":"Gastrointestinal Involvement in extra-digestive disease: which is the role of fecal calprotectin","volume":"58","author":"Saviano","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.arr.2023.102143_bib53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","article-title":"Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease","volume":"50","author":"Schwiertz","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2023.102143_bib54","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/mds.28016","article-title":"Plasma short\u2010chain fatty acids in patients with Parkinson's disease","volume":"35","author":"Shin","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2023.102143_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.arr.2023.102143_bib56","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/IJGM.S20875","article-title":"Diurnal salivary cortisol concentrations in Parkinson\u2019s disease: increased total secretion and morning cortisol concentrations","author":"Skogar","year":"2011","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.arr.2023.102143_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0765.2005.00845.x","article-title":"Norepinephrine stimulates calprotectin expression in human monocytic cells","volume":"41","author":"Suryono","year":"2006","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.arr.2023.102143_bib58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2023.102143_bib59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/biology9050103","article-title":"Clinical features of Parkinson\u2019s disease: the evolution of critical symptoms","volume":"9","author":"V\u00e1radi","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.arr.2023.102143_bib60","doi-asserted-by":"crossref","first-page":"E607","DOI":"10.1002\/oby.20466","article-title":"Human intestinal microbiota composition is associated with local and systemic inflammation in obesity","volume":"21","author":"Verdam","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.arr.2023.102143_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00121","article-title":"Clinical features and correlates of excessive daytime sleepiness in Parkinson's disease","volume":"10","author":"Xiang","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2023.102143_bib62","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011337","article-title":"Gastrointestinal nervous system \u03b1-synuclein as a potential biomarker of Parkinson disease","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.arr.2023.102143_bib63","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.14336\/AD.2022.01281","article-title":"Intestinal permeability, dysbiosis, inflammation and enteric glia cells: the intestinal etiology of Parkinson\u2019s disease","volume":"13","author":"Yang","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.arr.2023.102143_bib64","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.parkreldis.2020.10.034","article-title":"Altered gut microbiota in Parkinson's disease patients\/healthy spouses and its association with clinical features","volume":"81","author":"Zhang","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2023.102143_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1046910","article-title":"A review of studies on gut microbiota and levodopa metabolism","volume":"14","author":"Zhong","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2023.102143_bib66","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/1673-5374.317981","article-title":"Association between inflammatory bowel diseases and Parkinson's disease: systematic review and meta-analysis","volume":"17","author":"Zhu","year":"2022","journal-title":"Neural Regen. Res."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723003021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723003021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:16:50Z","timestamp":1761592610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163723003021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":66,"alternative-id":["S1568163723003021"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2023.102143","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calprotectin in Parkinsonian disease: Anticipation and dedication","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2023.102143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102143"}}